Vascular invasion in Stage I Lung adenocarcinoma Implications

A Systematic Review into the Radiologic Features Predicting Local Recurrence

Chest CT Scan+CXR versus CXR for follow up

Lobar versus Sublobar Resection in the Elderly for Early Lung Cancer

RVLob Trial Short Term Results

Comparison of SBRT and RFA for Early Stage NSCLC A Systematic review

Panel Discussion - Local Therapy Issues

Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine

86P Aumolertinib as adjuvant therapy in postoperative EGFR mutated

Osimertinib as adjuvant therapy in patients with resected EGFRm stage IB IIIA

Patients Preferences for Adjuvant Osimertinib In Non Small Cell Lung Cancer

Panel discussion Adjuvant Systemic Therapy-TKI

Panel Discussion Systemic therapy in Operable NSCLC role for CPI in this setting

Neoadjuvant Nivolumab plus Platium Doublet Chemotherapy vs Chemo for resectable

Pembrolizumab versus Placebo as adjuvant therapy for completely resected IV IIIA

Nivolumab + platinum doublet Chemotherapy vs Chemotherapy as neoadjuvant treatment

Neoadjuvant nivolumab in early stage non stage non small cell lung cancer

Vascular invasion in Stage I Lung adenocarcinoma Implications

A Systematic Review into the Radiologic Features Predicting Local Recurrence

Chest CT Scan+CXR versus CXR for follow up

Lobar versus Sublobar Resection in the Elderly for Early Lung Cancer

Comparison of SBRT and RFA for Early Stage NSCLC A Systematic review

Panel Discussion - Local Therapy Issues

Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine

86P Aumolertinib as adjuvant therapy in postoperative EGFR mutated

Patients Preferences for Adjuvant Osimertinib In Non Small Cell Lung Cancer

Panel discussion Adjuvant Systemic Therapy-TKI

Panel Discussion Systemic therapy in Operable NSCLC role for CPI in this setting

Neoadjuvant Nivolumab plus Platium Doublet Chemotherapy vs Chemo for resectable

Pembrolizumab versus Placebo as adjuvant therapy for completely resected IV IIIA

Nivolumab + platinum doublet Chemotherapy vs Chemotherapy as neoadjuvant treatment

Neoadjuvant nivolumab in early stage non stage non small cell lung cancer